Transcatheter Aortic Valve Replacement: Procedure and Outcomes.
Aortic stenosis
Interventional cardiology
Outcomes
Paravalvular regurgitation
Structural valve deterioration
Transcatheter aortic valve replacement
Transcatheter heart valve
Journal
Cardiology clinics
ISSN: 1558-2264
Titre abrégé: Cardiol Clin
Pays: Netherlands
ID NLM: 8300331
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
11
6
2020
Statut:
ppublish
Résumé
Initially, transcatheter aortic valve replacement (TAVR) was only used in patients with severe symptomatic aortic stenosis and prohibitive risk for surgical aortic valve replacement. Subsequently, TAVR was extended to patients with high and intermediate surgical risk. Recently, the results of randomized trials in low-surgical-risk patients showed superiority or noninferiority of TAVR versus surgical aortic valve replacement in this population. Procedural outcomes have been improved. Long-term durability of transcatheter heart valves remains to be confirmed. This article presents the evolution and current status of TAVR, with respect to the different types of devices and procedures as well as its outcomes.
Identifiants
pubmed: 31753170
pii: S0733-8651(19)30085-2
doi: 10.1016/j.ccl.2019.09.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
115-128Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.